Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Factive (gemifloxacin mesylate) Tablets, 320 mg, GeneSoft NDA 21-158/S1 7/25/03 8/15/03 8/15/03 Factive (gemifloxacin mesylate) Tablets, 320 mg, LG Life Sciences, Ltd NDA 21-158 FACTIVE (gemifloxacin mesylate) Tablets, Parexel International, Labeling Revision FACTIVE (gemifloxacin mesylate) Tablets, Parexel International, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharma, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharma, New Dosage Regimen | Factive (gemifloxacin) Tablets, Oscient Pharma, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Package Change | Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Labeling Revision | Gemifloxacin Mesylate Tablets, Orchid Healthcare, Tentative Approval | Factive (gemifloxacin mesylate) Tablets, Cornerstone Therapeutics, Inc., Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Cornerstone Therapeutics, Inc., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com